Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Titan Medical Inc T.TMD

Alternate Symbol(s):  TMDIF

Titan Medical Inc. is a medical technology company. The Company is focused on the development and commercialization of surgical technologies for single access robotic assisted surgery (RAS) requiring only a single patient access point. It has integrated technology into the Enos surgical system with the purpose of enhancing the robotic assisted surgical experience for surgeons. The Enos surgeon workstation includes a three dimensional (3D) high-definition display to provide a crucial balance of surgical immersion and situational awareness in the operating room. The display is mounted to the ergonomic workstation with a natural handle interface designed to deliver and support comfortable surgical posture, even during long procedures. The Company's multi-articulated instruments bring fluid flexibility and strength to position the end effectors for grasping, suturing, cutting and coagulation.


TSX:TMD - Post by User

Comment by dmacdon Nov 12, 2021 12:16am
203 Views
Post# 34118138

RE:RE:Titan is Piling Up the Patents what's it's Worth?

RE:RE:Titan is Piling Up the Patents what's it's Worth?Problem is only SPACS have the vision to fund these ventures and value them properly. I will wait till 2024 to buy if they are still around. Risk of dilution is too high for me. Better returns between now in other plays like RHT and SCYX and BYSI if you want med cos. Made your mistake and learned my lesson ... the odds are not in your favour right now. Management were honest though so I hope they get the well deserved funding to see this thru.
<< Previous
Bullboard Posts
Next >>